Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SUPN
#1407
Supernus Pharmaceuticals, Inc.
54.730
0
+0.48%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.48%
Monthly Change
+10.77%
6 month change
+1.35%
Year Change
+1.35%
Previous Close
54.470
0
Open
54.730
0
Bid
Ask
Low
54.730
0
High
54.730
0
Volume
97
Markets
US Stock Market
Healthcare
SUPN
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
TD Cowen raises Supernus Pharmaceuticals stock price target on Onapgo relaunch
Supernus Pharmaceuticals stock hits 52-week high at $57.76
Cantor Fitzgerald reiterates Supernus stock Overweight on supply gains
Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates
Supernus earnings missed by $0.48, revenue topped estimates
Supernus faces earnings test after Q3 shock to profitability
Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to Decline
BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View
New Drugs Take Center Stage as Biogen Heads Into Q4 Earnings
Supernus - Outlook For 2026 Positive, Upholding Buy Rating (NASDAQ:SUPN)
Supernus Pharmaceuticals amends merger agreement to adjust milestone payments
Cantor Fitzgerald reiterates Overweight rating on Supernus Pharmaceuticals stock